D. Manimaran, N. Elangovan, and V. Palanisamy, “Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type”, Jordan j. pharm. sci., vol. 17, no. 4, pp. 783–793, Dec. 2024.